Literature DB >> 31899746

Deceptive and Nondeceptive Placebos to Reduce Pain: An Experimental Study in Healthy Individuals.

Tobias Kube1,2, Winfried Rief1, Maj-Britt Vivell1, N Leonora Schäfer1, Teresa Vermillion1, Karoline Körfer1, Julia A Glombiewski1,2.   

Abstract

OBJECTIVES: Recent research has shown that placebos can be effective even if they are openly prescribed to participants. Yet, it is unclear how such "open-label placebos" (OLPs) compare to deceptive placebo (DP) and what the mechanisms of actions are. In this study, we therefore compared 2 versions of OLP to DP and no treatment (NT).
MATERIALS AND METHODS: Using a standard heat pain paradigm, 117 healthy volunteers underwent a baseline and a posttreatment pain assessment. With the exception of NT, all groups received an inert placebo cream after the first assessment. OLP was administered by either evoking positive expectancies or by raising hope for placebo analgesia, thus distinguishing for the first time conceptually between expectancy and hope in experimental pain research. The primary outcome was pre-post change in pain tolerance.
RESULTS: Increase in pain tolerance was larger in the 3 treatment groups compared with NT, whereas the treatment groups did not differ from each other. Further results showed that participants receiving DP reported a large reduction of subjective pain intensity and unpleasantness, whereas no such reduction was found for the 2 OLP groups. The 2 OLP versions did not differ in terms of their analgesic effects. DISCUSSION: The study provided evidence for traditional placebo analgesia on the basis of deception. For OLP, we found that OLP indeed increased pain tolerance; however, participants receiving OLP were reluctant to report any subjective analgesic effects. Combined with previous studies, the present findings suggest that the effects of OLP are weaker in healthy volunteers than in clinical samples.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31899746     DOI: 10.1097/AJP.0000000000000781

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  7 in total

1.  How orthopedic surgeons view open label placebo pills: Ethical and effective, but opposed to personal use.

Authors:  Michael H Bernstein; Maayan Rosenfield; Nathaniel Fuchs; Molly Magill; Charlotte R Blease; Francesca L Beaudoin; Josiah D Rich; Karolina Wartolowska; Richard M Terek
Journal:  J Psychosom Res       Date:  2021-10-05       Impact factor: 3.006

2.  Treating Pain With Open-Label Placebos: A Qualitative Study With Post-Surgical Pain Patients.

Authors:  Michael H Bernstein; Nathaniel Fuchs; Maayan Rosenfield; Arnold-Peter Weiss; Charlotte Blease; Cosima Locher; Molly Magill; Josiah Rich; Francesca L Beaudoin
Journal:  J Pain       Date:  2021-05-15       Impact factor: 5.820

3.  Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial.

Authors:  Julian Kleine-Borgmann; Katharina Schmidt; Marieke Billinger; Katarina Forkmann; Katja Wiech; Ulrike Bingel
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.379

4.  Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis.

Authors:  Tobias Kube; Verena E Hofmann; Julia A Glombiewski; Irving Kirsch
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

5.  Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study.

Authors:  Julia W Haas; Giulio Ongaro; Eric Jacobson; Lisa A Conboy; Judy Nee; Johanna Iturrino; Vikram Rangan; Anthony Lembo; Ted J Kaptchuk; Sarah Ballou
Journal:  BMC Psychol       Date:  2022-02-04

6.  Expectations: How and when do they contribute to placebo analgesia?

Authors:  Sophie Rosenkjær; Sigrid Juhl Lunde; Irving Kirsch; Lene Vase
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

7.  Placebo, nocebo: Believing in the field of medicine.

Authors:  Karin Meissner
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.